GSK eyes sale of $1.2 billion consumer health drugs; says report Medical Dialogues Bureau22 Jun 2019 8:59 AM ISTGSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices Medical Dialogues Bureau8 Jun 2019 2:35 PM ISTAs per the CCI order, Himalaya Drug was fined Rs 18.59 crore while its three senior officials were fined a total of nearly Rs 4 lakh. Besides, Intas...
Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China Farhat Nasim3 Jun 2019 11:00 AM ISTDr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5 Meghna A Singhania6 May 2019 11:23 AM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Cadila Healthcare gets 14 USFDA observations for Moraiya plant Farhat Nasim4 May 2019 10:00 AM ISTThe US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court Meghna A Singhania3 May 2019 1:50 PM ISTMumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen Meghna A Singhania30 April 2019 10:16 AM ISTGlenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India Farhat Nasim30 April 2019 10:15 AM IST"SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension Farhat Nasim30 April 2019 10:00 AM ISTCipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report Farhat Nasim26 April 2019 2:20 PM ISTNew Delhi: Sun Pharmaceutical (Sun Pharma) Industries Ltd's Dadra plant has reportedly received 11 observations, "serious" in nature from the U.S....
Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis Farhat Nasim26 April 2019 12:49 PM ISTLeflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
Glenmark Pharma gets USFDA approval for generic version of VAGIFEM Farhat Nasim25 April 2019 10:50 AM ISTThe approved product Estradiol Vaginal Inserts USP, 10 mcg is a generic version of Novo Nordisk Inc's VAGIFEM. New Delhi: Glenmark Pharmaceuticals has...
